Cargando…
COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update
BACKGROUND: Solid organ transplant (SOT) recipients are a complex, immunocompromised population in whom greater coronavirus disease 2019 (COVID-19) mortality has been reported compared with the general population. METHODS: We examined a retrospective cohort of 58 SOT recipients with first-wave COVID...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904466/ https://www.ncbi.nlm.nih.gov/pubmed/33757628 http://dx.doi.org/10.1016/j.transproceed.2021.02.014 |
_version_ | 1783654935968088064 |
---|---|
author | Arya, Akanksha Li, Michael Aburjania, Nana Singh, Pooja Royer, Tricia Moss, Sean Belden, Katherine A. |
author_facet | Arya, Akanksha Li, Michael Aburjania, Nana Singh, Pooja Royer, Tricia Moss, Sean Belden, Katherine A. |
author_sort | Arya, Akanksha |
collection | PubMed |
description | BACKGROUND: Solid organ transplant (SOT) recipients are a complex, immunocompromised population in whom greater coronavirus disease 2019 (COVID-19) mortality has been reported compared with the general population. METHODS: We examined a retrospective cohort of 58 SOT recipients with first-wave COVID-19, comparing patients with severe and nonsevere illness. Additionally, SOT recipients are compared with general patients with first-wave COVID-19. RESULTS: Organs transplanted included 38 kidneys, 8 livers, 5 hearts, and 3 pancreases. Average SOT recipient age was 57.4 years; 62% were male; 46.6% were African American 36.2% were white. Comorbidities included hypertension (86%), chronic kidney disease (86%), diabetes mellitus (50%), coronary artery disease (26%), and chronic obstructive pulmonary disease (14%). Twenty patients had severe COVID-19 (34.5%) and 38 had nonsevere disease (65.5%). Severe disease was more common in older SOT recipients with comorbidities and was associated with cough, dyspnea, pneumonia, C-reactive protein >10 mg/L, and platelet count <150/μL. Sex, race, body mass index, time from transplant, baseline immunosuppression, and diagnosis month did not differ among those with severe and nonsevere COVID-19. Seventy percent of SOT recipients were hospitalized vs 27.2% of general patients with COVID-19 and inpatient SOT recipients had a higher mechanical ventilation rate. Though a trend toward longer length of stay, higher intensive care unit admission, and greater inpatient mortality was observed (19.5% vs 14.8%), these differences were not significant. CONCLUSIONS: The severe acute respiratory syndrome coronavirus 2 has greatly impacted SOT recipients. One-third of our SOT recipients seen during the first wave had severe illness with associated standard risk factors for poor outcome. Compared with general first-wave patients, more SOT recipients were hospitalized, although inpatient COVID-19 mortality did not significantly differ. |
format | Online Article Text |
id | pubmed-7904466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79044662021-02-25 COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update Arya, Akanksha Li, Michael Aburjania, Nana Singh, Pooja Royer, Tricia Moss, Sean Belden, Katherine A. Transplant Proc Article BACKGROUND: Solid organ transplant (SOT) recipients are a complex, immunocompromised population in whom greater coronavirus disease 2019 (COVID-19) mortality has been reported compared with the general population. METHODS: We examined a retrospective cohort of 58 SOT recipients with first-wave COVID-19, comparing patients with severe and nonsevere illness. Additionally, SOT recipients are compared with general patients with first-wave COVID-19. RESULTS: Organs transplanted included 38 kidneys, 8 livers, 5 hearts, and 3 pancreases. Average SOT recipient age was 57.4 years; 62% were male; 46.6% were African American 36.2% were white. Comorbidities included hypertension (86%), chronic kidney disease (86%), diabetes mellitus (50%), coronary artery disease (26%), and chronic obstructive pulmonary disease (14%). Twenty patients had severe COVID-19 (34.5%) and 38 had nonsevere disease (65.5%). Severe disease was more common in older SOT recipients with comorbidities and was associated with cough, dyspnea, pneumonia, C-reactive protein >10 mg/L, and platelet count <150/μL. Sex, race, body mass index, time from transplant, baseline immunosuppression, and diagnosis month did not differ among those with severe and nonsevere COVID-19. Seventy percent of SOT recipients were hospitalized vs 27.2% of general patients with COVID-19 and inpatient SOT recipients had a higher mechanical ventilation rate. Though a trend toward longer length of stay, higher intensive care unit admission, and greater inpatient mortality was observed (19.5% vs 14.8%), these differences were not significant. CONCLUSIONS: The severe acute respiratory syndrome coronavirus 2 has greatly impacted SOT recipients. One-third of our SOT recipients seen during the first wave had severe illness with associated standard risk factors for poor outcome. Compared with general first-wave patients, more SOT recipients were hospitalized, although inpatient COVID-19 mortality did not significantly differ. The Authors. Published by Elsevier Inc. 2021-05 2021-02-25 /pmc/articles/PMC7904466/ /pubmed/33757628 http://dx.doi.org/10.1016/j.transproceed.2021.02.014 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Arya, Akanksha Li, Michael Aburjania, Nana Singh, Pooja Royer, Tricia Moss, Sean Belden, Katherine A. COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update |
title | COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update |
title_full | COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update |
title_fullStr | COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update |
title_full_unstemmed | COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update |
title_short | COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update |
title_sort | covid-19 in solid organ transplantation: disease severity and clinical update |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904466/ https://www.ncbi.nlm.nih.gov/pubmed/33757628 http://dx.doi.org/10.1016/j.transproceed.2021.02.014 |
work_keys_str_mv | AT aryaakanksha covid19insolidorgantransplantationdiseaseseverityandclinicalupdate AT limichael covid19insolidorgantransplantationdiseaseseverityandclinicalupdate AT aburjanianana covid19insolidorgantransplantationdiseaseseverityandclinicalupdate AT singhpooja covid19insolidorgantransplantationdiseaseseverityandclinicalupdate AT royertricia covid19insolidorgantransplantationdiseaseseverityandclinicalupdate AT mosssean covid19insolidorgantransplantationdiseaseseverityandclinicalupdate AT beldenkatherinea covid19insolidorgantransplantationdiseaseseverityandclinicalupdate |